Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144K Sell
2,284
-720
-24% -$50.3K ﹤0.01% 510
2026
Q1
$227K Buy
3,004
+896
+43% +$63.9K ﹤0.01% 411
2025
Q4
$130K Hold
2,108
﹤0.01% 510
2025
Q3
$124K Sell
2,108
-60
-3% -$3.5K ﹤0.01% 522
2025
Q2
$126K Buy
2,168
+866
+67% +$48.9K ﹤0.01% 501
2025
Q1
$64.7K Buy
+1,302
New +$66.6K ﹤0.01% 601
2024
Q1
Sell
-30
Closed -$1.69K 990
2023
Q4
$1.69K Buy
+30
New +$1.7K ﹤0.01% 912
2023
Q3
Sell
-104
Closed -$6.14K 1033
2023
Q2
$6.14K Buy
104
+80
+333% +$5.09K ﹤0.01% 840
2023
Q1
$1.77K Buy
+24
New +$1.85K ﹤0.01% 930
2022
Q4
Sell
-24
Closed -$2K 982
2022
Q3
$2K Sell
24
-2
-8% -$172 ﹤0.01% 919
2022
Q2
$2K Buy
+26
New +$2.52K ﹤0.01% 963

Other funds holding NTR

HM Payson & Co's NTR Position: Q2 2026 in Review

HM Payson & Co reduced its Nutrien (NTR) stake by 24% in Q2 2026, selling an estimated $50.3K and leaving 2,284 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #510.

HM Payson & Co first reported a position in NTR in Q2 2022 and has held it in 11 quarters since. The position peaked at $227K in Q1 2026. 135 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • HM Payson & Co held 2,284 shares of Nutrien worth $144K as of Q2 2026.
  • HM Payson & Co sold 720 Nutrien shares in Q2 2026, an estimated $50.3K.
  • Nutrien made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #510 holding.
  • HM Payson & Co first reported a position in Nutrien in Q2 2022 and has held it in 11 quarters since.
  • HM Payson & Co's Nutrien position peaked at $227K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.